Ilio-femoral and femoro-femoral crossover grafting. Analysis of an 11-year experience.
Journal of Cardiovascular Surgery 1983 November
Experience with 131 crossover arterial bypass grafts for lower limb revascularization has been reviewed. Ninety-nine grafts were placed as a primary procedure for unilateral iliac artery occlusive (97) or aneurysmal (2) disease. In contrast 32 grafts were placed as a secondary procedure following the failure of a previous unilateral or bilateral conventional aorto-iliac reconstruction. Fifteen patients were not suitable for a crossover procedure without the addition of a concomitant donor limb inflow reconstruction. The one month operative mortality rate was 6.1%. The five-year cumulative patency rate was 71.4% +/- 6.0 in primary procedures and 38.1% +/- 11.3 in secondary procedures (p less than 0.05). No difference in the success rate was shown when the vein graft patency curve was compared with the synthetic graft patency curve. However, the use of a small caliber vein (6 mm or less) resulted in the lowest patency rate. No other factors affecting patency were found. This report tends to support the fact that ilio-femoral or femoro-femoral crossover bypass is a safe and effective procedure for managing unilateral iliac artery occlusive disease. With proper selection of patients, a wider use of the method is justified.
Full text links
Trending Papers
Carvedilol, probably the β-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!Liver International : Official Journal of the International Association for the Study of the Liver 2023 June
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.Nature Reviews. Rheumatology 2023 May 10
Advances in Acute Ischemic Stroke Treatment: Current Status and Future Directions.AJNR. American Journal of Neuroradiology 2023 May 19
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app